Managing Erectile Dysfunction in Patients with Cardiovascular Disease
Introduction to Erectile Dysfunction Management
- The American College of Cardiology recommends starting with phosphodiesterase type 5 (PDE5) inhibitors as first-line therapy for erectile dysfunction (ED) in patients with stable cardiovascular status, while also implementing aggressive lifestyle modifications and optimizing medical management of coronary disease 1, 2
Cardiovascular Risk Assessment and Safety Considerations
- The European Heart Journal suggests assessing exercise capacity to determine if sexual activity is safe for patients who can exercise at 5 METs without angina, excessive dyspnea, ischemic ST-segment changes, hypotension, or arrhythmia 3, 4
- Patients with stable coronary disease who are asymptomatic or have no ischemia during stress testing are at low risk for sexual activity-triggered cardiovascular events, according to the European Heart Journal 3, 4
- The American College of Cardiology recommends screening for absolute contraindications, such as nitrate use, unstable angina, uncontrolled hypertension, or recent MI/stroke within 90 days, before prescribing PDE5 inhibitors 1
First-Line Pharmacological Treatment
- The American College of Cardiology recommends initiating oral PDE5 inhibitor therapy as first-line treatment, with options including tadalafil, sildenafil, vardenafil, and avanafil 1, 2
- Sildenafil can be started at 50-100 mg as needed, according to Praxis Medical Insights 2, 7
- The expected efficacy of PDE5 inhibitors is a 60-65% success rate in the general population, though patients with cardiovascular disease may have slightly lower response rates, as reported by Praxis Medical Insights 2
Mandatory Lifestyle Modifications and Risk Factor Management
- The European Heart Journal recommends smoking cessation, which reduces total mortality by 36% in coronary disease patients and improves endothelial function 4, 2
- Regular aerobic exercise decreases peak coital heart rate and reduces the risk of sexual activity-triggered MI, according to the European Heart Journal 3, 4, 2
- Weight loss has been shown to improve erectile function in obese men with moderate ED, as reported by the European Heart Journal 3, 4
Optimizing Medical Therapy
- The American College of Cardiology recommends reviewing and adjusting cardiovascular medications, considering alternatives to beta-blockers, which confer a 3 times higher risk of erectile dysfunction, according to Circulation 5, 6, 2
- Testosterone assessment and replacement may be necessary, as PDE5 inhibitors require adequate testosterone levels for full efficacy, as reported by Praxis Medical Insights 2, 7
Psychosexual Counseling
- Psychosexual therapy is an essential adjunct to treatment, with success rates of 50-80% when combined with physical therapies, according to Praxis Medical Insights 2, 8
- Partner involvement is essential for optimal outcomes, as reported by Praxis Medical Insights 2, 8